https://www.selleckchem.com/pr....oducts/qnz-evp4593.h
This study aimed to analyze the effects of sodium-glucose cotransporter2 (SGLT2) inhibitors on the indexes of liver fibrosis in patients with type2 diabetes mellitus complicated with non-alcoholic fatty liver disease, and also to observe the effects on liver enzymes and liver fat. This meta-analysis was performed using RevMan 5.3 statistical software. SGLT2 inhibitors could significantly reduce the level of hepatic fibrosis index fibrosis-4 (mean difference [MD] 0.25, 95% CI -0.39 to -0.11, p=0.0007); serum typeⅣ collagen 7s (MD 0.3
Like
Comment
Share
